Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome

scientific article published in September 2005

Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/08916930500246339
P698PubMed publication ID16278146

P50authorYehuda ShoenfeldQ1515807
Miri BlankQ73247232
P2093author name stringLevite M
Ganor Y
Dobrynina LA
Goldberg-Stern H
Kalashnikova L
P2860cites workThrombosis, abortion, cerebral disease, and the lupus anticoagulantQ24675412
CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARISQ28201845
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against EpilepsyQ28243859
Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitisQ28245345
LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptorQ28360498
The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosusQ33333901
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsQ33341941
Unusual manifestations of the antiphospholipid syndromeQ33348373
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse modelQ33499900
Ketogenic diet, amino acid metabolism, and seizure controlQ34464773
Poststroke seizuresQ34530025
Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndromeQ34735687
Central nervous system involvement in the antiphospholipid (Hughes) syndromeQ35069507
CNS dysfunction in the antiphospholipid syndromeQ35625224
Antiphospholipid syndrome infectious originQ35680777
Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomyQ36793709
Immunotherapy for epilepsyQ37610210
Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding siteQ41354036
Labeling of rat neurons by anti-GluR3 IgG from patients with Rasmussen encephalitisQ43684869
GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.Q43775117
Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizuresQ44233555
Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients' sera.Q44260531
Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures.Q46501393
Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA.Q46566884
Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.Q46615869
Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis.Q47801338
Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?Q48140719
Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.Q48144813
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomesQ48245672
Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitisQ48283010
Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders.Q54024916
P433issue6
P921main subjectantiphospholipid syndromeQ582207
P304page(s)417-424
P577publication date2005-09-01
P1433published inAutoimmunityQ4826348
P1476titleAntibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome
P478volume38

Reverse relations

cites work (P2860)
Q79843433Autoantibodies: a novel etiology for refractory epilepsy?
Q36473943Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome).
Q38235715Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilep
Q26738436Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.

Search more.